Neuspera Medical Receives Investigational Device Exemption for Its Ultra-Miniaturized Implantable Device

Regulatory Approval to Start Phase I of its Pivotal Trial SAN JOSE, Calif., Dec. 10, 2019 -- (Healthcare Sales & Marketing Network) -- Neuspera Medical Inc., a clinical stage, private, venture capital backed neuromodulation company, announced the recei... Devices, Urology, Neurology, FDA Neuspera Medical, neuromodulation, sacral nerve
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news